Articles and Blogs

On January 18, 2024, the Food and Drug Administration’s Office of Prescription Drug Promotion (“OPDP”) issued its first enforcement letter of the year. Last year, OPDP did not issue its first enforcement letter until July, as we discussed here, which makes us wonder whether we will see an increase in enforcement this year. As... READ MORE

After a slow start to the year, the Food and Drug Administration’s (“FDA”) Office of Prescription Drug Promotion (“OPDP”) now has a total of five enforcement letters for 2023 (four Untitled Letters and one Warning Letter) with potentially the last two letters of 2023 issued on Halloween. Our summary of the first three letters... READ MORE